CLINICAL_TRIALS
trial_result
· 2010-07-05
Clinical Trial Update: Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease [Phase 1]
Summary
This Phase 1 trial update reports on the safety and tolerability of NV1FGF in patients with severe Peripheral Arterial Occlusive Disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Peripheral Arterial Occlusive Disease | Phase 1 | Status: COMPLETED